DoJ sues company for selling unapproved drugs and supplements

The US Department of Justice (DoJ) has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Elysium gets ChromaDex, Dartmouth vitamin patents invalidated

23 September 2021 Dietary supplements company Elysium Health has convinced a Delaware court to invalidate two vitamin B3 patents belonging to rival ChromaDex and Dartmouth College.

Americas

Ukrainians plead guilty to trafficking counterfeit drugs into the US

20 July 2020 Two citizens of Ukraine have admitted to smuggling and distributing counterfeit cancer and hepatitis drugs into the US at the Southern District Court of Texas on July 17, according to the US Department of Justice.

Americas

DoJ weighs in on Amgen v Sandoz biosimilar clash

14 September 2017 The US Department of Justice (DoJ) has voiced its opinion on the biosimilar dispute between Amgen and Sandoz.